VENABLE LLP for ENDO PHARMACEUTICALS INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to incentives for life sciences research. H.R. 160- Protect Medical Innovation Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Copyright/Patent/Trademark CPT
Oversight of implementation of the America Invents Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Health Issues HCR
Issues relating to prescription drug abuse; Issues relating to incentives for tamper-resistant formulations; H.R. 471 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Issues relating to the labeling of generic drugs; Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H.R. 106. Issues relating to bioequivalence and related administrative procedures; Issues relating to incentives for tamper-resistant formulation, Issues relating to Medicare Part D rebates; Issues relating to products containing high doses of acetaminophen.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.